2026 NPPES data Transplant Surgery Physician NPI 1982710869 MD
Verify on CMS →

CHARLES BRATTON, MD

Transplant Surgery Physician in LOMA LINDA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 168 beneficiaries · Transplant Surgery Physician avg: 275
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.186/100
▲ 2 pts above national avg 83.1 · [object Object]
Industry payments
$621.13
14 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHARLES BRATTON, MD reported a CMS MIPS final score of 85.186/100 — above the 83.1 national average — and filed 1,865 Medicare Part D claims in 2023.

85.186/100
MIPS score · +2 vs avg
2K
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHARLES BRATTON, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

85 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

CHARLES BRATTON, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CHARLES BRATTON, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/22/2006

NPI 1982710869

Primary specialty

Transplant Surgery Physician

Niche

1,026 US NPIs in this specialty

Medicare Part D claims

1,865 578% vs specialty avg

2023 prescription claims

Specialty avg: 275

MIPS final score

85.186/100 2.0860000000000127% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Transplant Surgery Physician compares to other specialties among California providers

California providers

Transplant Surgery Physician share within California

1. Transplant Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Transplant Surgery Physician share within California

Medicare quality performance — MIPS

CHARLES BRATTON, MD's 2023 MIPS final score plotted against the Transplant Surgery Physician national average

High performer (top quartile)
MIPS Final Score
85.186/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Transplant Surgery Physician) — 85.186/100 vs national avg 83.1

0%100%National avg83%85.2%
MIPS final score (Transplant Surgery Physician) — 85.186/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHARLES BRATTON, MD appears in the CMS NPPES registry as a Transplant Surgery Physician provider holding MD credentials at 25865 BARTON RD STE 101, LOMA LINDA, CA, 92354, with a listed phone of (843) 792-1414. NPI 1982710869 was issued on 08/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRATTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,865 prescription claims written by this provider, covering 168 Medicare beneficiaries and totaling roughly $353K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.186/100 for the 2023 performance year (Quality 71.8166, Cost 64.5435), compared with the national average of 83.1.

Transplant Surgery Physician is a narrow specialty nationwide, with 1,026 enrolled providers across 48 states and an average of 275 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

25865 BARTON RD STE 101
LOMA LINDA, CA 92354

Provider Details

NPI 1982710869
Specialty Transplant Surgery Physician
Credentials MD
Gender Male
NPI Issued 08/22/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.186
Final Score
Avg: 83.1
71.8166
Quality
64.5435
Cost
82
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where CHARLES BRATTON, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FACULTY PHYSICIANS AND SURGEONS OF LLUSM
LOMA LINDA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHARLES BRATTON, MD. Source: openpaymentsdata.cms.gov.

Total received

$621

Largest payer

Mallinckrodt Hospital Products Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to CHARLES BRATTON, MD. To verify CHARLES BRATTON, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

CHARLES BRATTON, MD — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 1,865 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,865
Total Claims
$353K
Total Drug Cost
168
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,023
Total Day Supply
58,239
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$209K
Generic Drug Cost
$139K
Antibiotic Claims
364

Patient Demographics

Average Patient Age
53.2 years
Avg HCC Risk Score
8.06
Gender Split
38% female / 62% male
Age Distribution
<65: 116, 65-74: 51, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHARLES BRATTON, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
294
Valganciclovir Hcl
232
Famotidine
153
Pantoprazole Sodium
137
Fluconazole
132
Prednisone
106
Amlodipine Besylate
78
Clotrimazole
62
Tamsulosin Hcl
44
Nifedipine Er
Nifedipine
41

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Transplant Surgery Physician Overview

How CHARLES BRATTON, MD fits within the Transplant Surgery Physician landscape nationally.

1,026
Transplant Surgery Physician Providers in US
48
States with Transplant Surgery Physician
275
Avg Claims per Provider

CHARLES BRATTON, MD's 1,865 claims are above the specialty average of 275.

Nearby Transplant Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BRATTON.

Compare Transplant Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHARLES BRATTON, MD's specialty?
CHARLES BRATTON, MD specializes in Transplant Surgery Physician and practices in LOMA LINDA, California. Credentials: MD.
How much does CHARLES BRATTON, MD prescribe under Medicare Part D?
In 2023, CHARLES BRATTON, MD wrote 1,865 Medicare Part D claims totaling $353K in drug costs for 168 beneficiaries.
What is CHARLES BRATTON, MD's Medicare quality score?
CHARLES BRATTON, MD has a CMS MIPS Final Score of 85.186/100 (Quality: 71.8166, Cost: 64.5435). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHARLES BRATTON, MD located?
CHARLES BRATTON, MD is located at 25865 BARTON RD STE 101, LOMA LINDA, CA, 92354. Phone: (843) 792-1414.
What is CHARLES BRATTON, MD's NPI number?
CHARLES BRATTON, MD's National Provider Identifier (NPI) is 1982710869, issued on 08/22/2006.
Does CHARLES BRATTON, MD prescribe more brand-name or generic drugs?
CHARLES BRATTON, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $209K in brand drug costs.
How many Transplant Surgery Physician providers are there in the US?
There are 1,026 Transplant Surgery Physician providers across 48 states in the US. The average Transplant Surgery Physician provider writes 275 Medicare Part D claims per year.
What drugs does CHARLES BRATTON, MD prescribe most often?
Based on 2023 Medicare Part D data, CHARLES BRATTON, MD's most frequently prescribed drugs include Sulfamethoxazole-Trimethoprim, Valganciclovir Hcl, Famotidine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHARLES BRATTON, MD accept Medicare?
CHARLES BRATTON, MD appears in CMS Medicare data with 1,865 Part D claims and 168 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHARLES BRATTON, MD's credentials?
CHARLES BRATTON, MD's NPI is 1982710869 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology